![Samantha Ludolf](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Samantha Ludolf worked as the Deputy Director-Strategy and Operations at The Walter & Eliza Hall Institute of Medical Research from 2013 to 2020.
Prior to that, she obtained an MBA from the University of Melbourne and an undergraduate degree from The University of Lincoln.
Anciens postes connus de Samantha Ludolf
Sociétés | Poste | Fin |
---|---|---|
The Walter & Eliza Hall Institute of Medical Research
![]() The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia. | Directeur des opérations | 01/01/2020 |
Formation de Samantha Ludolf
The University of Lincoln | Undergraduate Degree |
University of Melbourne | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
The Walter & Eliza Hall Institute of Medical Research
![]() The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia. | Commercial Services |